\Bridge7 Oncology\ is a Canadian startup founded in 2017\ with a focus on revolutionizing cancer care. Their slogan, "Bridge7 uses AI to scale clinical expertise to improve the efficiency, consistency and quality of delivering cancer care\," reflects their mission to bridge the gap between limited human experience and the increasing demand for cancer care globally. The company recently secured a Seed Round investment at 05 February 2020\ from FACIT\, signaling investor confidence in their innovative approach. As a player in the Health Care\ industry, Bridge7 Oncology aims to ensure that every patient has access to high-quality cancer care, and their use of intelligent solutions underscores their commitment to this cause.\
General Information
BounceWatch is an independent company data service, not affiliated with bridge7 Oncology. To contact bridge7 Oncology, visit bridge7.ai.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
About bridge7 Oncology
Taxonomy: clinical expertise, cancer care, oncology, precision medicine
Funding Rounds & Investors (3)
View Allbridge7 Oncology Alternatives & Competitors
View All AlternativesAncora.ai is a patient-first, digital clinical trial navigation tool connecting cancer patients to c...
We deliver AI-driven cancer care and clinical trial access to transform early detection for underser...
FAQ About bridge7 Oncology
Source: BounceWatch company record for bridge7 Oncology, https://bouncewatch.com/company/bridge7-oncology, updated 14 January 2025. When citing, please name BounceWatch and link this page.